CVRx, Inc.
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve sympto…
Medical - Devices
US, Minneapolis [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about CVRx, Inc.'s gradings, price targets and earnings estimates. None
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2021 | - | -4.047 | - | 13 | - | -83 | - | -13 | - | -13 | - | 22 |
| 2022 | -2.1100 | -2.062 | 13 | 22 | -43 | -39 | -40 | -37 | -25 | -39 | 27 | 38 |
| 2023 | -2.0200 | -2.090 | 22 | 39 | -41 | -41 | -40 | -42 | -42 | -45 | 50 | 67 |
| 2024 | -1.9900 | -2.571 | 39 | 50 | -41 | -53 | -38 | -50 | -43 | -50 | 64 | 87 |
| 2025 | - | -2.061 | - | 64 | - | -41 | - | -64 | - | -64 | - | 110 |
| 2026 | - | 1.F5X/td> | - | 1.F5X/td> | - | 1.F5X/td> | - | 1.F51/td> | - | 1.F51 | - | 1.F51 |
| 2027 | - | 0.F6X/td> | - | 0.F6X/td> | - | 0.F6X/td> | - | 0.F61/td> | - | 0.F61 | - | 0.F61 |